- Home
- BRY vs NKTR Comparison
BRY vs NKTR Comparison
Compare BRY & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRY
- NKTR
- Stock Information
- Founded
- BRY 1909
- NKTR 1990
- Country
- BRY United States
- NKTR United States
- Employees
- BRY N/A
- NKTR N/A
- Industry
- BRY Oil & Gas Production
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- BRY Energy
- NKTR Health Care
- Exchange
- BRY Nasdaq
- NKTR Nasdaq
- Market Cap
- BRY 186.1M
- NKTR 108.3M
- IPO Year
- BRY N/A
- NKTR 1994
- Fundamental
- Price
- BRY $3.24
- NKTR $24.76
- Analyst Decision
- BRY Buy
- NKTR Strong Buy
- Analyst Count
- BRY 2
- NKTR 6
- Target Price
- BRY $5.00
- NKTR $77.50
- AVG Volume (30 Days)
- BRY 1.3M
- NKTR 4.6M
- Earning Date
- BRY 08-08-2025
- NKTR 08-07-2025
- Dividend Yield
- BRY 3.87%
- NKTR N/A
- EPS Growth
- BRY N/A
- NKTR N/A
- EPS
- BRY N/A
- NKTR N/A
- Revenue
- BRY $753,737,000.00
- NKTR $87,248,000.00
- Revenue This Year
- BRY N/A
- NKTR N/A
- Revenue Next Year
- BRY $0.96
- NKTR N/A
- P/E Ratio
- BRY N/A
- NKTR N/A
- Revenue Growth
- BRY N/A
- NKTR N/A
- 52 Week Low
- BRY $2.11
- NKTR $6.48
- 52 Week High
- BRY $7.02
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- BRY 57.06
- NKTR 68.00
- Support Level
- BRY $2.70
- NKTR $8.27
- Resistance Level
- BRY $3.07
- NKTR $26.59
- Average True Range (ATR)
- BRY 0.17
- NKTR 3.71
- MACD
- BRY -0.01
- NKTR 1.18
- Stochastic Oscillator
- BRY 51.45
- NKTR 57.06
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.